Bair Teresa Brophy

Track

Insider profile

Performance

Overall performance
2.9
Performance over holding periods
2.9
30 days 90 days 120 days
Average return -4% 8.2% 15.1%
Success rate 43% 68% 82%
Transactions
8 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Bair Teresa Brophy's trades of Kura Oncology Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Planned sale
Price
325.27
Quantity 94,637 +24.0%
Value US$1,957,605
Transaction date
Proposed sale
Price
389.33
Quantity 52,608
Value US$2,684,418
Transaction date
Planned sale
Price
427.73
Quantity 93,702 -13.0%
Value US$654,904
Transaction date
Proposed sale
Price
9.22
Quantity 2,256
Value US$20,800
Transaction date
Proposed sale
Price
8.47
Quantity 11,208
Value US$94,932
Transaction date
Sale
Price
8.46
Quantity 4,777 -2.1%
Value US$40,417
Transaction date
Sale
Price
8.46
Quantity 2,335 -1.0%
Value US$19,756
Transaction date
Sale
Price
8.46
Quantity 4,096 -1.7%
Value US$34,655
Transaction date
Proposed sale
Price
10.68
Quantity 8,804
Value US$94,027
Transaction date
Sale
Price
11.18
Quantity 8,804 -4.5%
Value US$98,401
Transaction date
Proposed sale
Price
9.05
Quantity 8,805
Value US$79,685
Transaction date
Sale
Price
8.94
Quantity 8,805 -5.6%
Value US$78,736
Transaction date
Planned sale
Price
5.96
Quantity 1,559 -1.4%
Value US$9,292
Transaction date
Proposed sale
Price
7.77
Quantity 7,281
Value US$56,573
Transaction date
Sale
Price
7.87
Quantity 4,844 -4.3%
Value US$38,131
Transaction date
Sale
Price
7.87
Quantity 2,437 -2.1%
Value US$19,184
Transaction date
Proposed sale
Price
22.15
Quantity 2,615
Value US$57,916
Transaction date
Planned sale
Price
22.15
Quantity 2,615 -3.7%
Value US$57,916
Transaction date
Sale
Price
17.80
Quantity 2,053 -2.9%
Value US$36,544
Transaction date
Planned sale
Price
15.22
Quantity 2,100 -100.0%
Value US$31,965
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-08-21 2026-08-19
PlS Planned sale
94,637 +24.0%
325.27
US$1,957,605 		94,637 +24.0% 325.27 US$1,957,605
2026-08-19 2026-08-19
PrS Proposed sale
52,608
389.33
US$2,684,418 		52,608 389.33 US$2,684,418
2026-05-20 2026-05-18
PlS Planned sale
93,702 -13.0%
427.73
US$654,904 		93,702 -13.0% 427.73 US$654,904
2026-05-18 2026-05-18
PrS Proposed sale
2,256
9.22
US$20,800 		2,256 9.22 US$20,800
2026-01-27 2026-01-27
PrS Proposed sale
11,208
8.47
US$94,932 		11,208 8.47 US$94,932
2026-01-27 2026-01-27
S Sale
4,777 -2.1%
8.46
US$40,417 		4,777 -2.1% 8.46 US$40,417
2026-01-27 2026-01-27
S Sale
2,335 -1.0%
8.46
US$19,756 		2,335 -1.0% 8.46 US$19,756
2026-01-27 2026-01-27
S Sale
4,096 -1.7%
8.46
US$34,655 		4,096 -1.7% 8.46 US$34,655
2025-11-14 2025-11-14
PrS Proposed sale
8,804
10.68
US$94,027 		8,804 10.68 US$94,027
2025-11-14 2025-11-14
S Sale
8,804 -4.5%
11.18
US$98,401 		8,804 -4.5% 11.18 US$98,401
2025-09-29 2025-09-29
PrS Proposed sale
8,805
9.05
US$79,685 		8,805 9.05 US$79,685
2025-09-29 2025-09-29
S Sale
8,805 -5.6%
8.94
US$78,736 		8,805 -5.6% 8.94 US$78,736
2025-05-19 2025-05-19
PlS Planned sale
1,559 -1.4%
5.96
US$9,292 		1,559 -1.4% 5.96 US$9,292
2025-01-28 2025-01-28
PrS Proposed sale
7,281
7.77
US$56,573 		7,281 7.77 US$56,573
2025-01-28 2025-01-28
S Sale
4,844 -4.3%
7.87
US$38,131 		4,844 -4.3% 7.87 US$38,131
2025-01-28 2025-01-28
S Sale
2,437 -2.1%
7.87
US$19,184 		2,437 -2.1% 7.87 US$19,184
2024-05-20 2024-05-20
PrS Proposed sale
2,615
22.15
US$57,916 		2,615 22.15 US$57,916
2024-05-20 2024-05-20
PlS Planned sale
2,615 -3.7%
22.15
US$57,916 		2,615 -3.7% 22.15 US$57,916
2024-01-31 2024-01-29
S Sale
2,053 -2.9%
17.80
US$36,544 		2,053 -2.9% 17.80 US$36,544
2022-11-18 2022-11-17
PlS Planned sale
2,100 -100.0%
15.22
US$31,965 		2,100 -100.0% 15.22 US$31,965